ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
- Status
- UNKNOWN
- Phase
- PHASE1
Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Corrected QT Interval Effects of Trastuzumab Emtansine (T-DM1) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy
- Status
- COMPLETED
- Phase
- NA